FDA Clears Personalized Brain Stimulation Treatment for PTSD Showing High Remission Rates

A new personalized brain stimulation treatment for Post-Traumatic Stress Disorder (PTSD), developed by Wave Neuroscience and Texas A&M researchers, has received FDA clearance. Clinical trial findings report a 52% reduction in PTSD symptoms and a 68% remission rate using personalized brain mapping and magnetic stimulation, offering a drug-free alternative for patients unresponsive to existing therapies.